Journal
CHEMISTRY AND PHYSICS OF LIPIDS
Volume 200, Issue -, Pages 94-103Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.chemphyslip.2016.08.002
Keywords
Cystic fibrosis; Sphingolipids; Lipid rafts; Inflammation
Categories
Funding
- Italian Cystic Fibrosis Research Foundation (FFC) [24/2014, 22/2015, 9/2015, 18/2009, 19/2011, 17/2014]
Ask authors/readers for more resources
Cystic fibrosis (CF), one of the most common lethal hereditary diseases of white European populations, is caused by loss-of-function mutations in the CF Transmembrane conductance Regulator (CFTR) gene. One of the main causes of mortality is the onset of CF lung disease, which is characterized by chronic infection and inflammation resulting in the progressive remodelling, irreversible damage and fibrosis of the airways. An increasing number of studies indicate that sphingolipids are crucial players in pulmonary manifestations of CF, even if their direct involvement in CF lung disease is still unclear. In this review, we give an overview of the role of sphingolipids in CF pulmonary disease, focusing on the relationship between glycosphingolipids and lung inflammation, which represents the main hallmark of this disease. (C) 2016 The Author(s). Published by Elsevier Ireland Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available